It is hoped that findings from the NIHR-funded trial will help better inform treatment decisions

Zejula is the first PARP inhibitor to be approved as monotherapy in the EU for patients with platinum-responsive […]

The oral, once-daily therapy is designed to prevent attacks and reduce burden of therapy

Updated Date: Fri, 23 Oct 2020 00:00:00 EDT

Updated Date: Fri, 23 Oct 2020 00:00:00 EDT

Updated Date: Fri, 23 Oct 2020 00:00:00 EDT

Updated Date: Fri, 23 Oct 2020 00:00:00 EDT

Updated Date: Fri, 23 Oct 2020 00:00:00 EDT

Coombes is absolutely right to point out that “GPs are in pole position to care for those who […]

bmj;371/oct30_7/m4174/FAF1faMargaret Mary Heley (“Maire”) was born in St Albans. Despite problems with school science teaching, she later won […]